Los Angeles, USA, July 14th, 2025, Chainwire
Will Place Streamex as one of many first NASDAQ-listed SEC and FINRA Compliant Issuers of RWA Tokens within the U.S.
BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig”), which lately merged with Streamex Exchange Corporation (“Streamex”) (collectively, “BSGM” or the “Firm”), is happy to announce a important step towards turning into one of many first totally regulated Actual-World Asset (“RWA”) tokenization firms buying and selling on a significant United States alternate: Streamex has engaged Compliance Exchange Group (CXG) to guide and handle the acquisition of a selected FINRA and SEC-registered broker-dealer with licensed operations.
- Acquisition of the broker-dealer, as soon as full, will create an entity with a big first-mover benefit in U.S.-major-exchange-traded RWA-backed tokenized funding alternatives for each main institutional and retail buyers within the U.S.
- This functionality is anticipated to considerably speed up adoption and community impact development of Streamex’s proprietary on-chain RWA commodity market platform.
- The Firm will even proceed to hunt out different broker-dealer alternatives in different strategically advantageous nations.
Administration notes that the near-term imaginative and prescient is to offer entry to completely compliant, gold-backed tokenized belongings for U.S. institutional and retail buyers focusing on the $22 trillion international gold market throughout the $142 trillion commodities sector, whereas participating network-effect-based accelerating development for the Streamex proprietary on-chain RWA-backed commodity alternate and financing ecosystem.
Strategic Advantages After Acquisition:
- First-Mover Benefit: Streamex will probably be among the many first Nasdaq-listed firms to concern regulated, gold-backed RWA tokens.
- Regulatory Compliance: Full compliance with each FINRA and SEC rules, aligning with rising U.S. digital asset frameworks.
- Scalable Platform: Streamex’s Solana-based blockchain allows quick, low-cost issuance and buying and selling of gold-backed tokens, making gold funding accessible to all, with further commodities markets to return.
- Gold-Backed Progress: Streamex goals to carry important portions in vaulted gold by 2026, denominating its stability sheet in bodily gold to assist a recurring income mannequin.
Why It Issues
Close to time period, the acquisition positions Streamex to bridge conventional finance and blockchain, providing a seamless technique to spend money on bodily gold by digital tokens. Buyers can purchase fractional shares of gold with the benefit of cryptocurrency, whereas companies acquire new methods to lift capital. This transfer aligns with international tendencies, as establishments like BlackRock and Goldman Sachs tokenize billions in belongings, and U.S. regulators start to make clear digital asset guidelines.
“The acquisition will probably be a defining second for Streamex and BioSig,” stated Henry McPhie, CEO of BioSig and Co-Founding father of Streamex. “Buying a regulated broker-dealer will assist us construct the infrastructure to guide the gold tokenization market within the U.S. Our Nasdaq itemizing and gold-backed platform will unlock unprecedented alternatives for buyers and reshape the $22trillion gold market.”
Morgan Lekstrom, Govt Chairman of the Firm, added: “Tokenizing gold is the way forward for commodity finance. Streamex’s regulated method and public market presence make it a pioneer on this transformative house, with the potential to redefine how buyers entry actual belongings.”
Concerning the Acquisition
The FINRA and SEC-registered broker-dealer, with a presence within the U.S., will present Streamex with the regulatory framework to concern and commerce tokenized belongings beneath federal securities legal guidelines. Compliance Alternate Group (CXG), a pacesetter in broker-dealer compliance, will oversee the acquisition to make sure seamless integration and adherence to rules. This acquisition is a important step towards scaling Streamex’s RWA tokenization platform nationwide.
About Streamex Alternate Company
Streamex is a gold treasury and infrastructure firm constructing the inspiration for on-chain commodity markets. With a concentrate on real-world asset (RWA) tokenization, Streamex is creating a vertically built-in platform that mixes token issuance, buying and selling infrastructure, and bodily gold holdings, positioning the Firm to change into considered one of Nasdaq’s largest public holders of gold bullion.
This strategic method aligns with Streamex’s mission to reshape international finance by bringing the roughly $142 trillion international commodities market on chain. By merging the safety and belief of bodily gold with the effectivity and transparency of blockchain, Streamex is creating scalable monetary infrastructure for a brand new period of digital commodities.
The Firm plans to carry important portions of bodily gold, securely vaulted by a top-tier bullion financial institution. Streamex will denominate the vast majority of its stability sheet in vaulted gold fairly than fiat forex, supporting a long-term, value-based monetary mannequin. Mixed with Streamex’s Solana-based blockchain infrastructure, this technique allows a recurring income mannequin that helps the issuance of gold-backed digital belongings.
Streamex is an entirely owned subsidiary of BioSig Applied sciences, Inc.
About Compliance Alternate Group (CXG)
CXG focuses on constructing, managing, and supporting Dealer-Seller infrastructure, providing full-service compliance, registration, principal outsourcing, and advisory companies.
About BioSig Applied sciences, Inc.
BioSig Technologies, Inc. is a medical system expertise firm with a sophisticated digital sign processing expertise platform, the PURE EP Platform, that delivers insights to electrophysiologists for ablation remedies of cardiovascular arrhythmias.
The PURE EP Platform allows electrophysiologists to amass uncooked sign information in real-time—absent pointless noise or interference—to maximise procedural success and decrease pointless inefficiencies. As doctor advocates, we consider that the flexibility to take care of the integrity of intracardiac alerts with precision and readability with out driving up procedural prices has by no means been extra pertinent.
Ahead-Trying Statements
This press launch accommodates “forward-looking statements” throughout the which means of the Non-public Securities Litigation Reform Act of 1995. Such statements could also be preceded by the phrases “intends,” “might,” “will,” “plans,” “expects,” “anticipates,” “initiatives,” “predicts,” “estimates,” “goals,” “believes,” “hopes,” “potential,” or related phrases. Ahead-looking statements will not be ensures of future efficiency, are primarily based on sure assumptions, and are topic to numerous identified and unknown dangers and uncertainties, a lot of that are past our management. It’s attainable that our precise outcomes and monetary situation might differ, probably materially, from the anticipated outcomes and monetary situation indicated in these forward-looking statements, relying on elements together with whether or not we will understand the advantages of the acquisition of Streamex, whether or not shareholder approval of the acquisition will probably be obtained, and whether or not we will preserve compliance with Nasdaq’s itemizing standards in reference to the acquisition and in any other case. For a dialogue of different dangers and uncertainties, and different necessary elements, any of which might trigger our precise outcomes to vary from these contained in forward-looking statements, see our filings with the Securities and Alternate Fee, together with the part titled “Danger Components” in our Annual Report on Kind 10-Okay, filed with the SEC on April 15, 2025. We assume no obligation to publicly replace or revise our forward-looking statements on account of new data, future occasions or in any other case, besides as required by regulation.
Contacts
Press Contact
Phoenix MGMT
PR@phoenixMGMTConsulting.com
Investor Relations Contact
Henry McPhie
CEO of BioSig, Co-Founding father of Streamex
contact@Streamex.com
